The NIDCD's clinical trials cooperative groups: a brief overview

Area of Science:

• Communication Sciences and Disorders
• Clinical Research Methodology
• Public Health Initiatives

Background:

• A scientific research need prompted the establishment of clinical trials cooperative groups (CTCGs) by the National Institute on Deafness and Other Communication Disorders (NIDCD) in 1996.
• The NIDCD aimed to address the efficacy of therapeutic interventions for communication disorders through well-designed clinical trials.
• Multicenter trials are often necessary due to the large patient populations required for statistical power.

Purpose of the Study:

• To detail the complexities inherent in conducting multicenter clinical trials for communication disorders.
• To outline the NIDCD's strategies for promoting clinical trials activities.
• To highlight efforts in developing training opportunities for clinical trialists in this specialized research area.

Main Methods:

• Establishment of two clinical trials cooperative groups (CTCGs) by the NIDCD.
• Development and implementation of standardized clinical trial protocols across multiple study sites.
• Coordination of activities through a complex administrative structure to ensure regulatory compliance.

Main Results:

• The NIDCD successfully initiated CTCGs to address research needs in communication disorders.
• Standardized protocols, treatment regimens, and data collection were implemented across participating sites.
• The initiative highlighted the necessity for experienced clinical trial leadership and specialized training.

Conclusions:

• Conducting multicenter clinical trials for communication disorders presents significant administrative and logistical challenges.
• The NIDCD's establishment of CTCGs represents a strategic effort to advance research in human communication disorders.
• There is an ongoing need to foster expertise and training for clinical trialists in this field.